Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4946038018 | Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4946039014 | Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Is a | Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Is a | Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Has active ingredient | Sulfamethoxazole | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Has active ingredient | Trimethoprim | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Has active ingredient | Isoniazid | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Has active ingredient | Pyridoxine | true | Inferred relationship | Existential restriction modifier | 4 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR